REGISTERED
on 10 Dec 2024
Last Applicant/ Owned by
6005 Hidden Valley Road
Carlsbad
CA
92011
Serial Number
90263391 filed on 19th Oct 2020
Registration Number
7599711 registered on 10th Dec 2024
Correspondent Address
Aaron D. Hendelman
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
GENETAC
pharmaceutical research and products development for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development of therapeutics for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregula Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
pharmaceutical research and products development for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development of therapeutics for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development in the field of small molecule therapeutics; scientific research for medical purposes in the field of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; medical and scientific research in the field of pharmaceuticals, all of the foregoing related to therapies that target nucleic acids and modulate gene expression
First Use Date in General
06th Aug 2024
First Use Date in Commerce
06th Aug 2024
Class [005]
Pharmaceutical Products
pharmaceutical preparations for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; therapeutic pharmaceuticals for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; small molecule therapies for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation, all of the foregoing related to therapies that target nucleic acids and modulate gene expression
First Use Date in General
05th Aug 2024
First Use Date in Commerce
05th Aug 2024
Mark Details
Serial Number
No 90263391
Mark Type
No Service Mark
Attorney Docket Number
No 56009-TM1001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Dec 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 10th Dec 2024 | REGISTERED-PRINCIPAL REGISTER |
| 18th Nov 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 18th Nov 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 12th Nov 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 12th Nov 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 10th Sep 2024 | TEAS STATEMENT OF USE RECEIVED |
| 10th Sep 2024 | USE AMENDMENT FILED |
| 30th Apr 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 29th Apr 2024 | SOU TEAS EXTENSION RECEIVED |